Literature DB >> 16960805

Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families.

Mary L McMaster1, Lynn R Goldin, Yan Bai, Monica Ter-Minassian, Stefan Boehringer, Therese R Giambarresi, Linda G Vasquez, Margaret A Tucker.   

Abstract

Waldenstrom macroglobulinemia (WM), a distinctive subtype of non-Hodgkin lymphoma that features overproduction of immunoglobulin M (IgM), clearly has a familial component; however, no susceptibility genes have yet been identified. We performed a genomewide linkage analysis in 11 high-risk families with WM that were informative for linkage, for a total of 122 individuals with DNA samples, including 34 patients with WM and 10 patients with IgM monoclonal gammopathy of undetermined significance (IgM MGUS). We genotyped 1,058 microsatellite markers (average spacing 3.5 cM), performed both nonparametric and parametric linkage analysis, and computed both two-point and multipoint linkage statistics. The strongest evidence of linkage was found on chromosomes 1q and 4q when patients with WM and with IgM MGUS were both considered affected; nonparametric linkage scores were 2.5 (P=.0089) and 3.1 (P=.004), respectively. Other locations suggestive of linkage were found on chromosomes 3 and 6. Results of two-locus linkage analysis were consistent with independent effects. The findings from this first linkage analysis of families at high risk for WM represent important progress toward identifying gene(s) that modulate susceptibility to WM and toward understanding its complex etiology.

Entities:  

Mesh:

Year:  2006        PMID: 16960805      PMCID: PMC1592553          DOI: 10.1086/507687

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Parametric and nonparametric multipoint linkage analysis with imprinting and two-locus-trait models: application to mite sensitization.

Authors:  K Strauch; R Fimmers; T Kurz; K A Deichmann; T F Wienker; M P Baur
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

2.  Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors.

Authors:  R G Owen; S L Barrans; S J Richards; S J O'Connor; J A Child; L A Parapia; G J Morgan; A S Jack
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

3.  Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees.

Authors:  E Sobel; H Sengul; D E Weeks
Journal:  Hum Hered       Date:  2001       Impact factor: 0.444

4.  Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms.

Authors:  A Altieri; J L Bermejo; K Hemminki
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

5.  Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples.

Authors:  Lynn R Goldin; Ola Landgren; Mary L McMaster; Gloria Gridley; Kari Hemminki; Xinjun Li; Lene Mellemkjaer; Jørgen H Olsen; Martha S Linet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

6.  Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.

Authors:  Mary L McMaster; Therese Giambarresi; Linda Vasquez; Alisa M Goldstein; Margaret A Tucker
Journal:  Clin Lymphoma       Date:  2005-03

7.  Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.

Authors:  Gerassimos A Pangalis; Maria-Christina Kyrtsonis; Flora N Kontopidou; Marina P Siakantaris; Maria N Dimopoulou; Theodoros P Vassilakopoulos; Tatiana Tzenou; Styliani Kokoris; Evangelia Dimitriadou; Christina Kalpadakis; Kaliroe Tsalimalma; Panagiotis Tsaftaridis; Panagiotis Panayiotidis; Maria K Angelopoulou
Journal:  Clin Lymphoma       Date:  2005-03

8.  Characterization of familial Waldenstrom's macroglobulinemia.

Authors:  S P Treon; Z R Hunter; A Aggarwal; E P Ewen; S Masota; C Lee; D Ditzel Santos; E Hatjiharissi; L Xu; X Leleu; O Tournilhac; C J Patterson; R Manning; A R Branagan; C C Morton
Journal:  Ann Oncol       Date:  2005-12-15       Impact factor: 32.976

9.  Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.

Authors:  A Mansoor; L J Medeiros; D M Weber; R Alexanian; K Hayes; D Jones; R Lai; A Glassman; C E Bueso-Ramos
Journal:  Am J Clin Pathol       Date:  2001-10       Impact factor: 2.493

10.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

View more
  21 in total

Review 1.  Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Casey Philipsborn; Anne Novak; Lucy Hodge; Stephen Ansell; Rafael Fonseca
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

Review 2.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

Review 3.  Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Ingemar Turesson; Magnus Björkholm; Ola Landgren
Journal:  Acta Haematol       Date:  2012-02-03       Impact factor: 2.195

Review 4.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

5.  Chronic immune stimulation and subsequent Waldenström macroglobulinemia.

Authors:  Jill Koshiol; Gloria Gridley; Eric A Engels; Mary L McMaster; Ola Landgren
Journal:  Arch Intern Med       Date:  2008-09-22

Review 6.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

Review 7.  Novel treatment options for Waldenström macroglobulinemia.

Authors:  Houry Leblebjian; Amit Agarwal; Irene Ghobrial
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-09

8.  Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Jonathan J Keats; Xavier Leleu; Scott Van Wier; Victor H Jimenez-Zepeda; Riccardo Valdez; Roelandt F J Schop; Tammy Price-Troska; Kimberly Henderson; Antonio Sacco; Feda Azab; Philip Greipp; Morie Gertz; Suzanne Hayman; S Vincent Rajkumar; John Carpten; Marta Chesi; Michael Barrett; A Keith Stewart; Ahmet Dogan; P Leif Bergsagel; Irene M Ghobrial; Rafael Fonseca
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 9.  Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.

Authors:  Elisabet E Manasanch; Sigurdur Y Kristinsson; Ola Landgren
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-03-07

10.  Common genetic variants in candidate genes and risk of familial lymphoid malignancies.

Authors:  Xueying Sharon Liang; Neil Caporaso; Mary Lou McMaster; David Ng; Ola Landgren; Meredith Yeager; Stephen Chanock; Lynn R Goldin
Journal:  Br J Haematol       Date:  2009-07-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.